$SLNO
SOLENO THERAPEUTICS INC

2020 Q4 Form 10-K Financial Statement

#000156459021010569 Filed on March 03, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.250M $8.760M $1.610M
YoY Change 39.75% 26.41% 17.52%
% of Gross Profit
Research & Development $5.570M $23.19M $5.270M
YoY Change 5.69% 42.56% 140.64%
% of Gross Profit
Depreciation & Amortization $480.0K $11.00K $490.0K
YoY Change -2.04% 0.0% 0.0%
% of Gross Profit
Operating Expenses $7.820M $36.29M $6.880M
YoY Change 13.66% 54.51% 93.26%
Operating Profit -$36.29M
YoY Change 54.51%
Interest Expense $0.00 $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $5.110M $11.65M -$7.870M
YoY Change -164.93% -259.85% -507.77%
Pretax Income -$2.850M -$24.64M -$14.63M
YoY Change -80.52% -19.82% -3851.28%
Income Tax
% Of Pretax Income
Net Earnings -$2.850M -$24.64M -$14.63M
YoY Change -80.52% -19.94% -5726.92%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$35.75K -$393.5K -$354.8K
COMMON SHARES
Basic Shares Outstanding 44.66M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.22M $49.22M $20.73M
YoY Change 137.43% 137.43% -13.91%
Cash & Equivalents $49.22M $49.22M $20.73M
Short-Term Investments $0.00
Other Short-Term Assets $1.020M $1.020M $410.0K
YoY Change 148.78% 148.78% -22.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.24M $50.24M $21.14M
YoY Change 137.62% 137.65% -14.29%
LONG-TERM ASSETS
Property, Plant & Equipment $19.00K $160.0K $22.00K
YoY Change -13.64% -63.64% 83.33%
Goodwill
YoY Change
Intangibles $14.58M $16.53M
YoY Change -11.76% -10.53%
Long-Term Investments
YoY Change
Other Assets $15.00K $0.00 $59.00K
YoY Change -74.58% -100.0%
Total Long-Term Assets $14.74M $14.74M $17.03M
YoY Change -13.44% -13.45% -7.86%
TOTAL ASSETS
Total Short-Term Assets $50.24M $50.24M $21.14M
Total Long-Term Assets $14.74M $14.74M $17.03M
Total Assets $64.98M $64.98M $38.17M
YoY Change 70.23% 70.24% -11.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.489M $3.490M $1.995M
YoY Change 74.89% 74.5% 113.6%
Accrued Expenses $4.930M $4.930M $2.590M
YoY Change 90.35% 90.35% 175.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00K
YoY Change -50.0%
Total Short-Term Liabilities $8.618M $8.620M $4.964M
YoY Change 73.61% 73.79% 164.46%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $10.82M $10.82M $147.0K
YoY Change 7260.54% -40.71% -98.65%
Total Long-Term Liabilities $10.82M $10.82M $147.0K
YoY Change 7260.54% -40.74% -98.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.618M $8.620M $4.964M
Total Long-Term Liabilities $10.82M $10.82M $147.0K
Total Liabilities $19.44M $19.44M $23.23M
YoY Change -16.32% -16.32% 82.33%
SHAREHOLDERS EQUITY
Retained Earnings -$182.4M -$157.8M
YoY Change 15.61% 24.23%
Common Stock $228.0M $172.8M
YoY Change 31.98% 9.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.55M $45.55M $14.95M
YoY Change
Total Liabilities & Shareholders Equity $64.98M $64.98M $38.17M
YoY Change 70.23% 70.24% -11.54%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$2.850M -$24.64M -$14.63M
YoY Change -80.52% -19.94% -5726.92%
Depreciation, Depletion And Amortization $480.0K $11.00K $490.0K
YoY Change -2.04% 0.0% 0.0%
Cash From Operating Activities -$6.860M -$25.22M -$5.080M
YoY Change 35.04% 45.17% 36.19%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $7.000K $0.00
YoY Change -66.67%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $110.0K
YoY Change -100.0% -100.0% -164.71%
Cash From Investing Activities -$10.00K -$7.000K $100.0K
YoY Change -110.0% -101.33% -158.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K 53.72M 14.48M
YoY Change -100.28% 270.98% -11.17%
NET CHANGE
Cash From Operating Activities -6.860M -25.22M -5.080M
Cash From Investing Activities -10.00K -7.000K 100.0K
Cash From Financing Activities -40.00K 53.72M 14.48M
Net Change In Cash -6.910M 28.49M 9.500M
YoY Change -172.74% -1304.18% -23.39%
FREE CASH FLOW
Cash From Operating Activities -$6.860M -$25.22M -$5.080M
Capital Expenditures -$10.00K $7.000K $0.00
Free Cash Flow -$6.850M -$25.23M -$5.080M
YoY Change 34.84% 45.04% 36.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62620227
CY2020Q4 slno Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
10278000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
147000
CY2020Q4 us-gaap Liabilities
Liabilities
19435000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79615692
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
79615692
CY2020 us-gaap Operating Expenses
OperatingExpenses
36289000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-36289000
CY2019 slno Income Loss From Minority Interest Investments
IncomeLossFromMinorityInterestInvestments
-478000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
21144000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
124000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
398000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
15000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
305000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
382000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
50243000
CY2019 slno Proceeds From Sale Of Common Stock And Common Stock Warrants Net Of Costs
ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfCosts
14483000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14481000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34142478
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
6964000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-157806000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-23486000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
154000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11650000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-24639000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
172708000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
14947000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7288000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-30774000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38172000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11637000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4964000
CY2020 slno Proceeds From Sale Of Common Stock And Common Stock Warrants Net Of Costs
ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfCosts
53722000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
17000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53722000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
30413000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
825000
CY2020 slno Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-305000
CY2019 slno Payments To Security Deposit On Sublease
PaymentsToSecurityDepositOnSublease
59000
CY2019 slno Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-360000
CY2019 slno Proceeds From Security Deposit Received From Expired Lease
ProceedsFromSecurityDepositReceivedFromExpiredLease
108000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-177000
CY2019 slno Proceeds From Sale Of Minority Interest Investment In Former Subsidiary
ProceedsFromSaleOfMinorityInterestInvestmentInFormerSubsidiary
500000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14483000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1500000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
17000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
53722000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
927000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3778000
CY2020 us-gaap Profit Loss
ProfitLoss
-24639000
CY2019 us-gaap Profit Loss
ProfitLoss
-30774000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1954000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1958000
CY2020 slno Noncash Lease Expense
NoncashLeaseExpense
283000
CY2019 slno Noncash Lease Expense
NoncashLeaseExpense
386000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1500000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
825000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-478000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
549000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-10000
CY2019 us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-64000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1494000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1061000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
722000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9000
CY2020 slno Increase Decrease In Accrued Clinical Trial Site Costs
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
1790000
CY2019 slno Increase Decrease In Accrued Clinical Trial Site Costs
IncreaseDecreaseInAccruedClinicalTrialSiteCosts
1679000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
36000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25224000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17375000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20733000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those estimates. Key estimates included in the financial statements include the valuation of deferred income tax assets, the valuation of financial instruments, stock-based compensation, accrued costs for services rendered in connection with third-party contactor clinical trial activities, value and life of acquired intangibles, and the valuation of contingent liabilities for the purchase price of assets obtained through acquisition. </p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentration of Credit Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents at one U.S. commercial bank. Cash and cash equivalents deposited with this commercial bank exceeded the Federal Deposit Insurance Corporation insurable limit at December&#160;31, 2020 and 2019. The Company expects the maintenance of balances in excess of insurable limits will continue. </p>
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31000
CY2020Q4 slno Concentration Risk Credit Risk Numberof Banks
ConcentrationRiskCreditRiskNumberofBanks
1
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
143000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
143000
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
8000
CY2020 us-gaap Depreciation
Depreciation
11000
CY2019 us-gaap Depreciation
Depreciation
11000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22003000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7422000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14581000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
22003000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5478000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16525000
CY2020 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1900000
CY2019 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1900000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
8000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
17000
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
8000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OtherLiabilitiesNoncurrent
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
305000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
418000
CY2019 us-gaap Sublease Income
SubleaseIncome
173000
CY2020 slno Operating Lease Cost And Sublease Income
OperatingLeaseCostAndSubleaseIncome
305000
CY2019 slno Operating Lease Cost And Sublease Income
OperatingLeaseCostAndSubleaseIncome
245000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
3000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
2000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2020 slno Finance Lease Cost
FinanceLeaseCost
11000
CY2019 slno Finance Lease Cost
FinanceLeaseCost
4000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
484000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
27000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
139000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
8000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
8000
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4M24D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.10
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.10
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4M24D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.10
CY2018Q4 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
2000000
CY2020 slno Gain Loss From Minority Interest Investment
GainLossFromMinorityInterestInvestment
33000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1500000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
825000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.76
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.14
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000
CY2020Q4 slno Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
10000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-22197000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-30729000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2442000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-45000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24639000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-30774000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5174000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6463000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2293000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1691000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
51000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
10000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8231000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6696000
CY2020 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
303000
CY2019 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
200000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
71000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
149000
CY2020 slno Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-2444000
CY2019 slno Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
1461000
CY2020 slno Income Tax Reconciliation Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationChangeInFairValueOfContingentConsideration
911000
CY2019 slno Income Tax Reconciliation Change In Fair Value Of Contingent Consideration
IncomeTaxReconciliationChangeInFairValueOfContingentConsideration
61000
CY2020 slno Income Tax Reconciliation Change In Net Operating Loss
IncomeTaxReconciliationChangeInNetOperatingLoss
-846000
CY2019 slno Income Tax Reconciliation Change In Net Operating Loss
IncomeTaxReconciliationChangeInNetOperatingLoss
725000
CY2019 slno Income Tax Reconciliation Change In State Rate True Up
IncomeTaxReconciliationChangeInStateRateTrueUp
701000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
104000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
1000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
41999000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
35091000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2803000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2349000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
236000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
77000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
63000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
71000
CY2020Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1115000
CY2019Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
1115000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
337000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
85000
CY2020Q4 slno Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
41000
CY2019Q4 slno Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
131000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
129000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
196000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46723000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39115000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4080000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4623000
CY2020Q4 slno Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
39000
CY2019Q4 slno Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
118000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4119000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4741000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
42604000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
34374000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
42604000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
34374000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
8200000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1111000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
4000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
216000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1323000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
964000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
7000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
4000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
144000
CY2020Q4 slno Unrecognized Assets And Liabilities Related To Uncertain Tax Positions
UnrecognizedAssetsAndLiabilitiesRelatedToUncertainTaxPositions
1300000
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2020Q4 slno Unrecognized Tax Benefits Offset By Valuation Allowance
UnrecognizedTaxBenefitsOffsetByValuationAllowance
1300000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4050926
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9438352
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
37000

Files In Submission

Name View Source Status
0001564590-21-010569-index-headers.html Edgar Link pending
0001564590-21-010569-index.html Edgar Link pending
0001564590-21-010569.txt Edgar Link pending
0001564590-21-010569-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slno-10k_20201231.htm Edgar Link pending
slno-20201231.xml Edgar Link completed
slno-20201231.xsd Edgar Link pending
slno-20201231_cal.xml Edgar Link unprocessable
slno-20201231_def.xml Edgar Link unprocessable
slno-20201231_lab.xml Edgar Link unprocessable
slno-20201231_pre.xml Edgar Link unprocessable
slno-ex211_10.htm Edgar Link pending
slno-ex231_9.htm Edgar Link pending
slno-ex311_6.htm Edgar Link pending
slno-ex312_8.htm Edgar Link pending
slno-ex321_7.htm Edgar Link pending
slno-ex322_11.htm Edgar Link pending